Go or no go? Biogen and Astellas head towards key PDUFAs

[cafead]

via Two of this year’s biggest FDA approval decisions are due next month, that of Astellas’s Zimura and Biogen/Sage’s zuranolone. The latter is filed in major depressive disorder and postpartum depression and is expected to be approved.

article source